Position
Chief Medical Officer
Company
VistaGen
South San FranciscoBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
On May 18, 2026, VistaGen Therapeutics appointed Angel S. Angelov, M.D., MBA, as Chief Medical Officer. This appointment highlights the company's commitment to advancing its neuropsychiatric and women's health programs.
Quick answer
VistaGen Therapeutics Appoints Angel S. Angelov as Chief Medical Officer (May 20, 2026). VistaGen is based in South San Francisco, California, United States.
- Who is the new Chief Medical Officer at VistaGen?
- VistaGen named Angel S. Angelov Chief Medical Officer, announced May 20, 2026.
- What did VistaGen announce on May 20, 2026?
- On May 18, 2026, VistaGen Therapeutics appointed Angel S. Angelov, M.D., MBA, as Chief Medical Officer. This appointment highlights the company's commitment to advancing its neuropsychiatric and women's health programs.
- What does VistaGen do?
- Vistagen is a late clinical-stage biopharmaceutical company headquartered in South San Francisco, CA, developing and commercializing a new class of intranasal product candidates called pherines.
- Where is VistaGen based?
- VistaGen is based in South San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- OnCusp Therapeutics (May 14, 2026), Retension Pharmaceuticals (May 27, 2026), TORL BioTherapeutics (May 7, 2026) and Poxel (June 10, 2026) also announced leadership changes within 45 days of VistaGen.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer (May 14, 2026)
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
- TORL BioTherapeutics Appoints Aran Maree, M.D., as Chief Executive Officer (May 7, 2026)
- Poxel Appoints Yves Decadt as Chief Executive Officer (June 10, 2026)
- Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager of Saudi Arabia and Gulf Countries (June 17, 2026)
- BridgeBio Oncology Therapeutics Appoints Pedro J. Beltran as CEO and Idan Elmelech as COO (April 22, 2026)
Who to call at VistaGen, and when
A new leader at VistaGen brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day VistaGen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VistaGen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VistaGen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VistaGen changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
VistaGen changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.